Il y a eu 50 transactions d'initiés récentes enregistrées pour Assembly Biosciences, Inc. (ASMB), dont 34 achats et 16 ventes. Le total des achats d'initiés s'élève à $50.76M et le total des ventes d'initiés à $109.06K.
Les initiés notables ayant une activité récente comprennent Bjorkquist Jeanette M, White Nicole S, Okazaki Jason A. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ASMB
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-30 |
Bjorkquist Jeanette M |
Pfo and Pao |
Vente Informative |
16 |
$27.49 |
$439.84 |
11,089 |
| 2026-03-30 |
White Nicole S |
Chief Manufacturing Officer |
Vente Informative |
9 |
$27.49 |
$247.41 |
37,477 |
| 2026-03-29 |
Okazaki Jason A |
CEO and President |
Attribution de RSU |
94,250 |
- |
- |
111,916 |
| 2026-03-29 |
Delaney William E Iv |
Chief Scientific Officer |
Attribution de RSU |
26,000 |
- |
- |
45,642 |
| 2026-03-29 |
Bjorkquist Jeanette M |
Pfo and Pao |
Attribution de RSU |
6,500 |
- |
- |
11,417 |
| 2026-03-29 |
White Nicole S |
Chief Manufacturing Officer |
Attribution de RSU |
26,000 |
- |
- |
37,674 |
| 2026-03-29 |
Gaggar Anuj |
Chief Medical Officer |
Attribution de RSU |
26,000 |
- |
- |
28,000 |
| 2025-08-08 |
Gilead Sciences, Inc. |
10 Percent Owner |
Achat Informatif |
1,147,960 |
$21.60 |
$24.8M |
1,147,960 |
| 2025-06-16 |
Bjorkquist Jeanette M |
Pfo and Pao |
Attribution de RSU |
600 |
$17.24 |
$10.34K |
600 |
| 2025-06-05 |
Altig Anthony E |
Director |
Attribution de RSU |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Ringo William R |
Director |
Attribution de RSU |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Mahony Susan |
Director |
Attribution de RSU |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Consylman Gina |
Director |
Attribution de RSU |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Mchutchison John G |
Director |
Attribution de RSU |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Johnson-pratt Lisa |
Director |
Attribution de RSU |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Houghton Michael |
Director |
Attribution de RSU |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-03-31 |
Okazaki Jason A |
CEO and President |
Vente Informative |
355 |
$9.85 |
$3.5K |
14,757 |
| 2025-03-31 |
Bjorkquist Jeanette M |
Principal Accounting Officer |
Vente Informative |
180 |
$9.85 |
$1.77K |
4,617 |
| 2025-03-31 |
White Nicole S |
Chief Manufacturing Officer |
Vente Informative |
197 |
$9.85 |
$1.94K |
11,674 |
| 2025-03-31 |
Mchutchison John G |
Director |
Vente Informative |
757 |
$9.85 |
$7.46K |
18,347 |
| 2025-03-29 |
Okazaki Jason A |
CEO and President |
Attribution de RSU |
71,100 |
$10.62 |
$755.08K |
71,100 |
| 2025-03-29 |
Delaney William E Iv |
Chief Scientific Officer |
Attribution de RSU |
25,500 |
$10.62 |
$270.81K |
25,500 |
| 2025-03-29 |
Bjorkquist Jeanette M |
Principal Accounting Officer |
Attribution de RSU |
1,900 |
$10.62 |
$20.18K |
1,900 |
| 2025-03-29 |
White Nicole S |
Chief Manufacturing Officer |
Attribution de RSU |
20,400 |
$10.62 |
$216.65K |
20,400 |
| 2025-03-29 |
Gaggar Anuj |
Chief Medical Officer |
Attribution de RSU |
24,200 |
$10.62 |
$257K |
24,200 |
| 2024-12-30 |
Houghton Michael |
Director |
Achat Informatif |
3,202 |
$15.61 |
$50K |
3,202 |
| 2024-12-19 |
Gilead Sciences, Inc. |
10 Percent Owner |
Achat Informatif |
940,499 |
$21.37 |
$20.1M |
2,209,471 |
| 2024-11-25 |
Schornstein Alexander |
10 Percent Owner |
Achat Informatif |
2,976 |
$15.00 |
$44.64K |
723,113 |
| 2024-11-22 |
Schornstein Alexander |
10 Percent Owner |
Achat Informatif |
17,024 |
$14.87 |
$253.1K |
720,137 |
| 2024-11-18 |
White Nicole S |
Chief Manufacturing Officer |
Vente Informative |
40 |
$16.29 |
$651.60 |
11,871 |
| 2024-10-08 |
Schornstein Alexander |
10 Percent Owner |
Achat Informatif |
10,000 |
$14.58 |
$145.8K |
703,113 |
| 2024-10-03 |
Okazaki Jason A |
CEO and President |
Vente Informative |
197 |
$14.81 |
$2.92K |
14,904 |
| 2024-10-03 |
White Nicole S |
Chief Manufacturing Officer |
Vente Informative |
157 |
$14.81 |
$2.33K |
11,911 |
| 2024-08-02 |
Okazaki Jason A |
CEO and President |
Vente Informative |
981 |
$14.23 |
$13.96K |
15,101 |
| 2024-08-02 |
White Nicole S |
Chief Manufacturing Officer |
Vente Informative |
785 |
$14.23 |
$11.17K |
12,068 |
| 2024-07-05 |
Schornstein Alexander |
10 Percent Owner |
Achat Informatif |
4,438 |
$12.52 |
$55.56K |
693,113 |
| 2024-07-03 |
Schornstein Alexander |
10 Percent Owner |
Achat Informatif |
4,562 |
$12.29 |
$56.07K |
688,675 |
| 2024-06-17 |
Gilead Sciences, Inc. |
10 Percent Owner |
Achat Informatif |
179,500 |
$17.00 |
$3.05M |
179,500 |
| 2024-05-29 |
Altig Anthony E |
Director |
Attribution de RSU |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Ringo William R |
Director |
Attribution de RSU |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Mahony Susan |
Director |
Attribution de RSU |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Consylman Gina |
Director |
Attribution de RSU |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Mchutchison John G |
Director |
Attribution de RSU |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Johnson-pratt Lisa |
Director |
Attribution de RSU |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Houghton Michael |
Director |
Attribution de RSU |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-23 |
Mchutchison John G |
Director |
Vente Informative |
2,117 |
$14.93 |
$31.61K |
19,104 |
| 2024-05-23 |
Okazaki Jason A |
CEO and President |
Vente Informative |
549 |
$14.93 |
$8.2K |
16,082 |
| 2024-05-23 |
Bjorkquist Jeanette M |
Principal Accounting Officer |
Vente Informative |
24 |
$14.93 |
$358.41 |
3,142 |
| 2024-05-23 |
White Nicole S |
Chief Manufacturing Officer |
Vente Informative |
172 |
$14.93 |
$2.57K |
12,853 |
| 2024-04-30 |
Okazaki Jason A |
CEO and President |
Vente Informative |
1,569 |
$12.71 |
$19.94K |
16,423 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
